2018-04-03T07:04:25-05:00 2017-06-30 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 650N BETHESDA MD 208142930 990 2016-07-01 237373091 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES AMER 7032999766 1001 NORTH FAIRFAX STREET NO 400 ALEXANDRIA VA 223141587 STEVEN ECHARD CEO 7032999766 2018-04-03 1 TERRI MCKNIGHT CPA P00543022 3019519090 75.103.231.202 2018-04-03 08:03:47 ED P 24E2B1EDDFB7997E904F8C8AA54720A5F314F67A 5FDD1FC65F72800D6105590239B9325DC3947F12 2016 2021-01-29 14:40:06Z STEVEN ECHARD 1001 NORTH FAIRFAX STREET NO 400 ALEXANDRIA VA 223141587 24972907 0 X WWW.AASLD.ORG X 1950 IL SEE PART III, LINE 1. 11 11 44 406 -45800 -45800 1028431 1117230 10761485 10843020 -296073 933073 2043777 1931993 13537620 14825316 1169500 1396311 0 0 4075708 4667261 0 0 28281 8540494 8812195 13785702 14875767 -248082 -50451 44194023 43810502 11009387 7934640 33184636 35875862 X TO ADVANCE AND DISSEMINATE THE SCIENCE AND PRACTICE OF HEPATOLOGY, AND TO PROMOTE LIVER HEALTH AND QUALITY PATIENT CARE. 0 1 6210482 17685 8316189 MEETINGS AND EDUCATION, INCLUDING THE ANNUAL MEETING: THE ASSOCIATION'S EDUCATIONAL PROGRAM ENABLES THE DISSEMINATION OF NEW TECHNIQUES AND ADVANCES IN EXISTING KNOWLEDGE AND PROCEDURES TO PHYSICIANS VIA FACE-TO-FACE MEETINGS AND ONLINE LEARNING. THE PROGRAM ALSO PROVIDES REGULAR OPPORTUNITIES FOR PHYSICIANS TO REVIEW BASIC AND CLINICAL TOPICS IN THEIR SPECIALTY TO PROMOTE THE ADVANCEMENT OF PATIENT CARE AND FOSTER NEW RESEARCH. THE LIVER MEETING, THE ASSOCIATION'S ANNUAL MEETING, OFFERS THE LATEST IN LIVER DISEASE TREATMENT OUTCOMES. ATTENDEES PARTICIPATE IN PLENARY, PARALLEL AND POSTER SESSIONS, STATE-OF-THE-ART LECTURES, EARLY MORNING WORKSHOPS, MEET-THE-PROFESSOR SESSIONS, SPECIALTY COURSES, SPECIAL INTEREST GROUP PROGRAMMING AND SCIENTIFIC EXHIBITS TO EXCHANGE THE LATEST LIVER DISEASE RESEARCH, DISCUSS TREATMENT OUTCOMES, AND INTERACT WITH COLLEAGUES. THE ASSOCIATION HOLDS SMALL STAND-ALONE MEETINGS SUCH AS THE CLINICAL HEPATOLOGY UPDATE COURSE, SINGLE TOPIC AND EMERGING TRENDS CONFERENCES, CO-SPONSORS DIGESTIVE DISEASE WEEK, AND COLLABORATES WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES, GOVERNMENT ENTITIES AND/OR OTHER NONPROFIT ORGANIZATIONS ON MUTUAL EDUCATIONAL PROGRAMMING IN HEPATOLOGY.AASLD'S ONLINE LEARNING OFFERINGS INCLUDE REGULAR WEBINARS ORGANIZED PRIMARILY BY THE ASSOCIATION'S SPECIAL INTEREST GROUPS ON VERY FOCUSED TOPICS THAT ARE RECORDED AND OFFERED ON-DEMAND THROUGH LIVERLEARNING, AASLD'S OFFICIAL E-LEARNING PORTAL. LIVERLEARNING IS AN ONLINE EDUCATIONAL REPOSITORY THAT ORGANIZES DIGITAL CONTENT FROM AASLD MEETINGS AND OTHER EDUCATIONAL OFFERINGS SUCH AS PRACTICE GUIDELINES AND COURSE HANDOUTS. AASLD IS ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME) TO OFFER AMA PRA CATEGORY 1 CREDIT. IN ADDITION, AASLD OFFERS MAINTENANCE OF CERTIFICATION (MOC) POINTS WHICH ARE AWARDED BASED ON THE SUCCESSFUL COMPLETION OF A CME PROGRAM FOR WHICH MOC IS ALSO OFFERED. MOC IS ULTIMATELY GRANTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE OR AMERICAN BOARD OF PEDIATRICS. 2228613 915388 PUBLICATIONS: "HEPATOLOGY", THE OFFICIAL JOURNAL OF THE ASSOCIATION, AND "LIVER TRANSPLANTATION" PROVIDE PEER-REVIEWED RESEARCH ON THE LIVER AND BILIARY TRACT AND THEIR DISEASES. "LIVER TRANSPLANTATION", A SPECIALTY JOURNAL, PUBLISHES STATE-OF-THE-ART INFORMATION ON LIVER TRANSPLANTATION. CLINICAL LIVER DISEASE (CLD) IS AN ONLINE LEARNING RESOURCE/JOURNAL THAT ADDRESSES TREATMENT ISSUES FACED BY HEPATOLOGISTS AND NONHEPATOLOGISTS WHEN SEEING PATIENTS WITH LIVER DISEASE. HEPATOLOGY COMMUNICATIONS IS A PEER-REVIEWED, ONLINE-ONLY OPEN ACCESS JOURNAL FOR FAST DISSEMINATION OF HIGH QUALITY BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH IN HEPATOLOGY. 2205069 1373126 96470 PROFESSIONAL RELATIONS: INCLUDES (1) AASLD PRACTICE GUIDELINES (2) PRACTICE METRICS COMMITTEE AND (3) RELATED SOCIETY COLLABORATIONS. (1) AASLD PRACTICE GUIDELINES: AASLD DEVELOPS CLINICAL PRACTICE GUIDELINES WHICH INCLUDE RECOMMENDATIONS THAT ARE SUPPORTED BY A HIGH LEVEL OF SCIENTIFIC EVIDENCE TO ASSIST PRACTITIONER AND PATIENT DECISIONS FOR APPROPRIATE HEALTH CARE RELATED TO SPECIFIC CLINICAL CIRCUMSTANCES. (2) PRACTICE METRICS COMMITTEE: THE PURPOSE OF THE COMMITTEE IS TO DEVELOP AND REVISE PERFORMANCE MEASURES THAT SERVE AS: - A MECHANISM TO EVALUATE QUALITY OF CARE PROVIDED TO PATIENTS WITH LIVER DISEASES, FROM BOTH THE PROVIDER AND PATIENT PERSPECTIVE- A STIMULUS FOR QUALITY IMPROVEMENT1. PROVIDE OVERSIGHT AND COORDINATION FOR ALL QUALITY IMPROVEMENT PROGRAMS WITHIN THE AASLD- SUCH AS THE CIRRHOSIS QUALITY COLLABORATIVE (CQC)2. ACTIVELY COORDINATE WITH OTHER COMMITTEES OF AASLD, AND WITH MEMBERS OF OTHER RELEVANT SPECIALTY SOCIETIES, ON ISSUES PERTAINING TO PATIENT SAFETY AND QUALITY IMPROVEMENT.(3) RELATED SOCIETY COLLABORATIONS: AASLD COLLABORATES WITH OTHER MEDICAL SOCIETIES BOTH DOMESTICALLY AND INTERNATIONALLY ON PROGRAMS AND ACTIVITIES THAT FURTHER THE SCIENCE AND PRACTICE OF HEPATOLOGY. MEMBER REPRESENTATIVES ARE SENT TO MEETINGS TO REPRESENT THE AASLD AND PROGRAMS ARE CREATED THAT BENEFIT AUDIENCES INTERESTED IN MUTUAL TOPICS OF INTEREST. 932830 5500 1514973 MEMBERSHIP & MENTORSHIP: AASLD'S MEMBERSHIP ENCOMPASSES ALL PROFESSIONALS DEDICATED TO HEPATOBILIARY DISCOVERIES AND PATIENT CARE. AASLD'S MEMBERS INCLUDE MORE THAN 5,500 DOMESTIC AND INTERNATIONAL PHYSICIANS, SCIENTISTS, HEPATOLOGISTS, SURGEONS, PATHOLOGISTS, AND ALLIED HEALTH PROFESSIONALS WHOSE PRACTICE OR RESEARCH INVOLVES THE FUNCTIONING AND DISORDERS OF THE LIVER AND BILIARY TRACT. THE AASLD MENTORSHIP PROGRAM IS DESIGNED TO PROMOTE THE STUDY OF HEPATOLOGY AMONG MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS, FELLOWS AND EARLY CAREER PROFESSIONALS WHO HAVE THE POTENTIAL FOR OR IS ALREADY IN A CAREER IN ACADEMIC MEDICINE. MEMBERS SERVE AS MENTORS TO THESE PROFESSIONALS, ENSURING THE CONTINUING AVAILABILITY OF KNOWLEDGEABLE, SKILLED, AND WELL-TRAINED HEPATOLOGISTS.WEBSITE: AASLD MAINTAINS A WEBSITE ALLOWING MEMBERS, SCIENTISTS, PHYSICIANS, ALLIED HEALTH PROFESSIONALS, AND OTHER VISITORS TO NAVIGATE AND FIND INFORMATION ABOUT THEIR AREAS OF INTEREST. (SITE VISITORS TOTAL GREATER THAN 370,000 ANNUALLY). 707873 COMMUNICATIONS: INCLUDES AASLD E-NEWS, WHICH IS PUBLISHED EVERY OTHER WEEK FOR THE AASLD MEMBERSHIP. ALSO INCLUDES MEDIA RELATIONS SURROUNDING RESEARCH PRESENTED AT THE ANNUAL MEETING, AS WELL AS MAJOR MILESTONES THROUGHOUT THE YEAR RELATED TO THE SOCIETY. AASLD DISSEMINATES INFORMATION ABOUT ADVANCES MADE IN THE TREATMENT OF PATIENTS WITH LIVER DISEASE AND POLICY DECISIONS THAT REFLECT CLINICIANS, RESEARCHERS, AND PATIENTS. 388545 CLINICAL AND PUBLIC POLICIES: AASLD CONDUCTS A PUBLIC AND CLINICAL POLICY PROGRAM, WHICH IS SUPERVISED BY THE PUBLIC POLICY COMMITTEE. IT HOLDS TWO EVENTS EACH YEAR: LIVER CAPITOL HILL DAY AND FEDERAL AGENCY DAY. IN THE FORMER, AASLD PARTNERS WITH PATIENT ADVOCACY ORGANIZATIONS TO EDUCATE CONGRESSIONAL LEGISLATORS AND STAFF ON ISSUES RELATED TO LIVER DISEASE RESEARCH AND PATIENT CARE. IN THE LATTER, AASLD DISCUSSES WITH KEY FEDERAL AGENCY PARTNERS WAYS IN WHICH AASLD CAN INFORM THE SCIENTIFIC COMMUNITY OF FEDERAL RESEARCH PRIORITIES. AASLD KEEPS ITS MEMBERS INFORMED OF LEGISLATIVE AND AGENCY DECISIONS THAT AFFECT HEPATOLOGY, AND ENCOURAGES THEM TO REMAIN INVOLVED IN PUBLIC POLICY ISSUES. 2029248 5500 1514973 12673412 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 130 0 1 44 1 1 1 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 0 1 1 AL AR CA CT GA HI IL KS MD MA MI MN MS NH NJ NM NY NC OR PA TN UT VA WI X BRUCE A LUXON 7032999766 1001 NORTH FAIRFAX STREET NO 400 ALEXANDRIA VA 223141587 ANNA SUK-FONG LOK PRESIDENT 5.00 X X 25000 0 0 RONALD J SOKOL PRESIDENT-ELECT 5.00 5.00 X X 0 0 0 KEITH D LINDOR PAST PRESIDENT 5.00 X X 50000 0 0 BRUCE A LUXON TREASURER 5.00 5.00 X X 3000 0 0 KIMBERLY ANN BROWN SECRETARY 5.00 X X 18000 0 0 JORGE A BEZERRA COUNCILOR 5.00 5.00 X 6250 0 0 MICHAEL W FRIED COUNCILOR 5.00 5.00 X 0 0 0 RAYMOND T CHUNG COUNCILOR 5.00 X 12500 0 0 MARK J CZAJA COUNCILOR AT LARGE 5.00 X 0 0 0 JULIE HEIMBACH COUNCILOR AT LARGE 5.00 X 0 0 0 LOPA MISHRA COUNCILOR AT LARGE 5.00 X 0 0 0 STEVEN ECHARD CHIEF EXECUTIVE OFFICER 40.00 2.00 X 425800 0 68621 NELLIE SARKISSIAN CHIEF OPERATIONS OFFICER 38.00 4.00 X 230216 0 32623 JULIE DEAL AASLD DEPUTY EXECUTIVE DIRECTOR/FDN ED 27.00 15.00 X 186702 0 35200 GREGORY BOLOGNA V.P., PUBLICATIONS AND PUBLIC POLICY 35.00 X 156150 0 27560 PAULA MCGRAW CHIEF TECHNOLOGY OFFICER 35.00 X 137792 0 23743 CHRISTOPHER DUGMORE DIRECTOR OF DATA INTEGRITY 35.00 X 131668 0 23429 DENISE SEISE ASSOCIATE V.P., MEETINGS & EDUCATION 35.00 X 132148 0 22433 JANEIL KLETT SR. DIR., EDUC. & PROF. DEVELOPMENT 35.00 X 124325 0 21854 1639551 0 255463 12 0 1 0 PSAV 23918 NETWORK PLACE CHICAGO IL 606731239 AUDIO VISUAL SERVICES 540334 JOHN WILEY & ASSOCIATES PO BOX 416502 BOSTON MA 022416502 PUBLISHER OF AASLD JOURNALS 472800 FREEMAN PO BOX 660613 DALLAS TX 75266 LOGISTICS MGMT. & MEETING SUPPORT 396280 LEVY RESTAURANTS 900 BOYLSTON STREET BOSTON MA 02115 FOOD AND BEVERAGE SERVICES 316184 MULTILEARNING GROUP INC 8782 RUE LAJEUNESSE MONTREAL QC CA H2M 1R6 AUDIO VISUAL SERVICES 205052 18 1117230 1117230 MEETINGS/EDUCATION 900099 8316189 8316189 MEMBERSHIP DUES 900099 1499627 1499627 PUBLICATIONS 900099 915388 915388 PROFESSIONAL RELATIONS 900099 96470 96470 CAREER DEVELOPMENT ADS 541800 15346 15346 10843020 885503 885503 1996249 1996249 89591 153847 -64256 -64256 -61146 -3110 10041314 9993744 47570 47570 47570 14825316 10827674 -45800 2926212 1368311 1368311 28000 28000 1190937 817802 365398 7737 2636763 2142726 491798 2239 249588 203058 46341 189 303797 240282 63090 425 286176 227803 57664 709 27998 3861 9596 14541 84791 41223 43568 21685 21685 1409256 1138777 270479 401000 380803 20197 283100 222177 60795 128 595930 483397 112379 154 850459 651608 196859 1992 859825 701616 158209 3108685 2951404 157281 57694 45866 11691 137 47669 32751 14918 PUBLISHERS FEES 821319 819513 1806 DUES & PROCESSING 92826 89542 3284 AGENCY TEMPORARY 60848 43955 16893 STAFF DEVELOPMENT 50232 14224 36008 38878 24713 14135 30 14875767 12673412 2174074 28281 4457167 2953466 457429 521973 1211084 1198084 547806 576282 519988 375844 9013293 2896635 6311858 6116658 30278475 31866186 410216 202009 44194023 43810502 651467 916527 1875120 1954759 3100000 3008440 5063354 2374360 0 11009387 7934640 X 27891500 30613636 2231286 2200376 3061850 3061850 33184636 35875862 44194023 43810502 -50451 2741677 0 X 0 1 X 1 0 X 2730636 5129804 761000 1028431 1117230 10767101 8606827 1514673 9458782 10747835 10827674 41155791 11337463 6644477 10219782 11776266 11944904 51922892 5000 5000 0 5000 5000 51917892 2726680 1062188 3662937 2855951 2971343 13279099 2726680 1062188 3662937 2855951 2971343 13279099 800 1413 17282 19495 14064943 7706665 13884132 14649499 14916247 65221486 0.79600 0.79230 0.20360 0.20730 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 106908 0 0 106908 0 PART II-B, LINE 1: AASLD PARTNERED WITH PATIENT ADVOCACY ORGANIZATIONS TO EDUCATE CONGRESSIONAL LEGISLATORS AND STAFF ON ISSUES RELATED TO LIVER DISEASE RESEARCH AND PATIENT CARE. 7385683 350528 380588 171498 7945301 7618332 38606 -27557 243698 7385683 7967801 -348155 104715 106029 7618332 7584441 260247 221514 98401 7967801 6055830 934120 700570 106079 7584441 0.38540 0.61460 0 0 8192735 2311696 5881039 665145 498125 167020 155413 86814 68599 6116658 X 17705255 2741677 6100 153847 2901624 14803631 21685 21685 14825316 15014029 6100 153847 159947 14854082 21685 21685 14875767 PART V, LINE 4: DONOR RESTRICTED ENDOWMENT ASSETS ARE HELD IN PERPETUITY AND INVESTED IN AN ATTEMPT TO PROVIDE A STREAM OF FUNDING TO PROGRAMS SUPPORTED BY ITS ENDOWMENT WHILE SEEKING TO MAINTAIN THE PURCHASING POWER OF THE ENDOWED ASSETS. BOARD DESIGNATED ASSETS ARE HELD FOR RESEARCH PROGRAMS AND AWARDS. PART X, LINE 2: FOR THE YEAR ENDED JUNE 30, 2017, THE ASSOCIATION HAS DOCUMENTED ITS CONSIDERATION OF FASB ASC 740-10, INCOME TAXES, THAT PROVIDES GUIDANCE FOR REPORTING UNCERTAINTY IN INCOME TAXES AND HAS DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS EXPENSES ON THE FINANCIAL 153,847. STATEMENTS AND NETTED AGAINST REVENUE ON FORM 990, PART VIII, LINE 6(B). PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS EXPENSES ON THE FINANCIAL 153,847. STATEMENTS AND NETTED AGAINST REVENUE ON FORM 990, PART VIII, LINE 6(B). 1 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS IN THE REGION 28000 0 0 0 0 0 0 28000 0 28000 EAST ASIA AND THE PACIFIC SPONSORSHIP 28000 WIRE 0 1 1 0 0 0 0 0 PART I, LINE 2: THE GRANT WAS GIVEN TO SUPPORT THE 2017 ASIA PACIFIC ASSOCIATION FOR THE STUDY OF LIVER (APASL) ANNUAL MEETING. 1 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION 1001 NORTH FAIRFAX STREET ALEXANDRIA VA 22314 464495751 501(C)(3) 1041128 TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE GORDON RESEARCH CONFERENCES 512 LIBERTY LANE WEST LIBERTY LANE RI 02892 260150662 501(C)(3) 10000 TO PROVIDE FUNDING FOR THE ALCOHOL-INDUCED END ORGAN DISEASES CONFERENCE ON MARCH 26-31, 2017 VIRGINIA COMMONWEALTH UNIVERSITY PO BOX 843035 RICHMOND VA 23284 546001758 501(C)(3) 74098 TO PROVIDE FUNDING FOR HEPATOBILIARY CANCERS: PATHOBIOLOGY AND TRANSLATIONAL ADVANCES CONFERENCE IN DECEMBER 2017/AASLD - INNOVATION FUND AWARD UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL PO BOX 402420 ATLANTA GA 303842420 566001393 501(C)(3) 51000 AASLD - INNOVATION FUND AWARD UNIVERSITY OF ARKANSAS 4301 WEST MARKHAM STREET LITTLE ROCK AR 72205 716046242 501(C)(3) 51500 AASLD - INNOVATION FUND AWARD THOMAS JEFFERSON UNIVERSITY 1020 WALNUT STREET PHILADELPHIA PA 19107 231352651 501(C)(3) 30000 AASLD - INNOVATION FUND AWARD BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MD 02115 042312909 501(C)(3) 43900 AASLD - INNOVATION FUND AWARD 7 0 PART I, LINE 2: AASLD SUPPORTS INNOVATION AWARDS TO SUPPORT HIGHLY CREATIVE IDEAS OR PROJECTS THAT ADVANCE AASLD'S MISSION TO ADVANCE AND DISSEMINATE THE SCIENCE AND PRACTICE OF HEPATOLOGY, AND TO PROMOTE LIVER HEALTH AND QUALITY PATIENT CARE. AWARDS RANGE IN SIZE FROM $10,000 TO $60,000 AND HAVE ONE OR TWO-YEAR TERMS. FUNDS CANNOT BE USED FOR SALARY SUPPORT FOR THE APPLICANT OR ANY AASLD MEMBERS, AND NO INDIRECT COSTS ARE ALLOWED. AASLD CLOSELY MONITORS AWARD RECIPIENTS THROUGH INTERIM PROGRESS REPORTS FROM THE RECIPIENT REGARDING PROJECT PROGRESS AND USE OF FUNDS. THE RECEIPT OF EACH SUBSEQUENT AWARD PAYMENT, DEPENDING ON AWARD TERM, IS CONTINGENT ON THE REVIEW AND APPROVAL OF INTERIM REPORTS BY THE INNOVATION FUND TASK FORCE. FINAL PROGRESS AND FISCAL REPORTS ARE REQUIRED AT THE END OF THE AWARD PERIOD. X X X X 0 0 0 0 0 0 0 1 0 STEVEN ECHARD CHIEF EXECUTIVE OFFICER 397300 0 28500 0 0 0 38000 0 30621 0 494421 0 0 0 NELLIE SARKISSIAN CHIEF OPERATIONS OFFICER 228216 0 2000 0 0 0 22500 0 10123 0 262839 0 0 0 JULIE DEAL AASLD DEPUTY EXECUTIVE DIRECTOR/FDN 184702 0 2000 0 0 0 18300 0 16900 0 221902 0 0 0 GREGORY BOLOGNA V.P., PUBLICATIONS AND PUBLIC POLICY 154150 0 2000 0 0 0 16029 0 11531 0 183710 0 0 0 PAULA MCGRAW CHIEF TECHNOLOGY OFFICER 137792 0 0 0 0 0 14085 0 9658 0 161535 0 0 0 CHRISTOPHER DUGMORE DIRECTOR OF DATA INTEGRITY 131668 0 0 0 0 0 13792 0 9637 0 155097 0 0 0 DENISE SEISE ASSOCIATE V.P., MEETINGS & EDUCATION 131148 0 1000 0 0 0 12875 0 9558 0 154581 0 0 0 PART I, LINE 7 THE FOLLOWING INDIVIDUALS RECEIVED BONUS COMPENSATION: S. ECHARD - $28,500 N. SARKISSIAN - $2,000 J. DEAL - $2,000 G. BOLOGNA - $2,000 D. SEISE - $1,000 FORM 990, PART III, LINE 3 LIVER LEARNING, AASLD'S OFFICIAL E-LEARNING PORTAL, HAS BEEN TRANSFERRED TO THE FOUNDATION. FORM 990, PART VI, SECTION A, LINE 6 AASLD MEMBERSHIP IS COMPRISED OF SCIENTISTS AND PHYSICIANS DEDICATED TO THE FIELD OF HEPATOLOGY AND ARE DIVIDED INTO SEVEN MEMBERSHIP CATEGORIES: REGULAR, EMERITUS, INTERNATIONAL, TRAINEE, ASSOCIATE, HONORARY, CORPORATE AFFILIATE AND FELLOW AASLD MEMBER. FORM 990, PART VI, SECTION A, LINE 7A AASLD'S REGULAR AND EMERITUS MEMBERS HAVE THE RIGHT TO ELECT THREE MEMBERS OF THE GOVERNING BODY. FORM 990, PART VI, SECTION A, LINE 7B CHANGES TO AASLD'S ARTICLES OF INCORPORATION AND BYLAWS ARE SUBJECT TO APPROVAL BY ITS MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B AFTER BEING PREPARED BY AASLD'S INDEPENDENT ACCOUNTING FIRM, THE FORM 990 IS REVIEWED BY SENIOR MANAGEMENT AND OUTSIDE LEGAL COUNSEL, THEN PROVIDED TO THE GOVERNING BOARD FOR REVIEW BEFORE BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C AN AASLD DISCLOSURE FORM IS COMPLETED BY ALL MEMBERS OF THE GOVERNING BOARD, COMMITTEES, AND TASK FORCES OF THE ASSOCIATION UPON NOMINATION AND/OR APPOINTMENT AND THEN ANNUALLY. THIS PROCESS ALSO APPLIES TO THE STAFF OF THE ASSOCIATION. THE FORM IS UPDATED THEREAFTER DURING EACH PERSON'S TENURE OF OFFICE, AS NECESSARY. COMMITTEE CHAIRS MAKE FORMS AVAILABLE AT ALL MEETINGS. IF IT IS DETERMINED THAT A CONFLICT EXISTS, THE ETHICS COMMITTEE ADVISES THE MEMBER TO TAKE ACTIONS INCLUDING THE FOLLOWING POSSIBLE ACTIONS: - DIVEST OR RESIGN FROM THE CONFLICT IN QUESTION. - ABSTAIN FROM DISCUSSION AND VOTING ON MATTERS INVOLVING THE CONFLICT. - EXCUSE HIM/HERSELF FROM PARTICIPATING IN SUCH MATTERS. - RESIGN FROM THE AASLD COMMITTEE OR OFFICE. FORM 990, PART VI, SECTION B, LINE 15A AASLD PERFORMS ANNUAL SALARY REVIEWS FOR EACH STAFF POSITION AND ADJUSTS COMPENSATION LEVELS AS NECESSARY. ANNUAL COMPENSATION SURVEYS ARE PERFORMED BY OUTSIDE CONSULTANTS EVERY TWO TO THREE YEARS. THE GOVERNING BOARD APPROVES/ADJUSTS THE CEO'S SALARY. THE CEO'S PERFORMANCE AND SALARY REVIEW ARE NOTED IN A LETTER FROM THE PRESIDENT OF AASLD TO THE CEO WITH A COPY TO THE ENTIRE GOVERNING BOARD. A COPY OF THE LETTER, ALONG WITH THE RELATED SUPPORTING DOCUMENTS, ARE IN THE CEO'S PERSONNEL FILE. THE CEO'S COMPENSATION WAS LAST REVIEWED IN MAY 2017. THE CEO APPROVES STAFF SALARY. STAFF SALARY DETERMINATION IS COMMUNICATED WITH STAFF ALONG WITH WRITTEN PERFORMANCE EVALUATION, WHICH IS CONDUCTED AT YEAR-END. INDIVIDUAL MEMORANDUMS FROM THE CEO TO INDIVIDUAL STAFF, COMMUNICATING THE SALARY CHANGE AND THE POSITION GRADE, ARE GIVEN TO INDIVIDUAL STAFF MEMBERS. COPIES OF THESE MEMORANDUMS ARE IN INDIVIDUALS' PERSONNEL FILES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON RECEIPT OF A BONAFIDE REQUEST. THE CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE ALSO AVAILABLE ON THE ORGANIZATION'S WEBSITE. FORM 990, PART X - SUBSEQUENT EVENT IN PREPARING THE FINANCIAL STATEMENTS, THE ASSOCIATION HAS EVALUATED EVENTS AND TRANSACTIONS FOR POTENTIAL RECOGNITION OR DISCLOSURE THROUGH OCTOBER 2017, THE DATE THE FINANCIAL STATEMENTS WERE ISSUED. ON AUGUST 1, 2016, THE ASSOCIATION REFINANCED ITS DEBT ASSOCIATED WITH THE PURCHASE AND CONSTRUCTION OF ITS OFFICE CONDOMINIUM INCLUDING: 1) THE REMAINDER PRINCIPAL DUE ON BOTH CONVENTIONAL LOANS, 2) THE REMAINDER PRINCIPAL ON THE TAX EXEMPT BONDS, AND 3) THE TOTAL INTEREST RATE SWAP OBLIGATIONS RELATED TO ALL THREE LOANS. THE ASSOCIATION REFINANCED THESE DEBTS WITH $3.0 MILLION FROM CASH AND INVESTMENT RESERVES AND ENTERED INTO A 10-YEAR NOTE PAYABLE IN THE AMOUNT OF $5,470,814 WITH A 3.26% FIXED INTEREST RATE AND A CLOSING COMMITMENT FEE OF 20 BASIS POINTS. THE NEW LOAN IS SECURED BY AASLD'S INVESTMENTS. THE LOAN AGREEMENT CONTAINS VARIOUS COVENANTS WHICH, AMONG OTHER THINGS, PLACE RESTRICTIONS ON THE ASSOCIATION'S ABILITY TO INCUR ADDITIONAL INDEBTEDNESS AND REQUIRES THE ASSOCIATION TO MAINTAIN CERTAIN FINANCIAL RATIOS. IN OCTOBER 2017, THE ASSOCIATION PAID OFF ALL OF ITS DEBT. AASLD FOUNDATION 1001 NORTH FAIRFAX STREET ALEXANDRIA VA 22314 464495751 INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND PEOPLE WHO STUDY LIVER DISEASE VA 501(C)(3) LINE 7 AASLD 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 AASLD FOUNDATION B 1041128 ACTUAL AMOUNT AASLD FOUNDATION N 137295 ACTUAL AMOUNT AASLD FOUNDATION O 116334 ACTUAL AMOUNT